当前位置: X-MOL 学术Anti-Cancer Drugs › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A case of polymorphic dermal angiitis in a B-cell chronic lymphocytic leukemia patient during rituximab therapy.
Anti-Cancer Drugs ( IF 1.8 ) Pub Date : 2021-08-16 , DOI: 10.1097/cad.0000000000001193
Elena Morozova 1 , Natalia Teplyuk , Olga Grabovskaya , Lyailya Kayumova , Liudmila Smirnova
Affiliation  

The aim of the study is to describe a case is of clinical interest as the first known occurrence of skin vasculitis during rituximab treatment. The article describes a case of polymorphic dermal angiitis, a combination of hemorrhagic and ulcerative-necrotic forms against the background of rituximab treatment in a 53-year-old woman suffering from chronic lymphocytic leukemia (b-CLL). During four hours after the 5th intravenous administration of rituximab, the appearance of painful rashes on the skin of both shins of a patient was observed. In the following few days, a progression of the pathological skin process was noted.

中文翻译:

B 细胞慢性淋巴细胞白血病患者在利妥昔单抗治疗期间发生多形性真皮血管炎一例。

该研究的目的是描述一个具有临床意义的病例,这是利妥昔单抗治疗期间首次已知发生的皮肤血管炎。该文章描述了一名患有慢性淋巴细胞白血病 (b-CLL) 的 53 岁女性在接受利妥昔单抗治疗的背景下发生多形性真皮血管炎的病例,该病是出血性和溃疡性坏死形式的结合。在第5次静脉注射利妥昔单抗后4小时内,观察到患者双胫骨皮肤上出现疼痛性皮疹。在接下来的几天里,注意到皮肤病理过程的进展。
更新日期:2021-08-16
down
wechat
bug